Literature DB >> 7622189

Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8.

M E Rottenberg1, A Riarte, L Sporrong, J Altcheh, P Petray, A M Ruiz, H Wigzell, A Orn.   

Abstract

Mice lacking CD4 and/or CD8 gene expression, generated by embryonic stem-cell technology, were used to study the role of CD4+ and CD8+ cells in the resistance to the acute infection with virulent (Tulahuén and RA) or mild (CA-I) strains of Trypanosoma cruzi. The presence of both CD4+ and CD8+ cells contributed to the survival of mice infected with T. cruzi, and each T-cell subtype was able to sustain protective functions in the absence of the other one. However, in certain host-parasite combinations, CD8+ cell-independent mechanisms were able to control the parasite load. Moreover, CD8- mice chronically infected with a low virulent strain of T. cruzi were protected from an otherwise lethal challenge with the parasite. A different organ distribution of parasite nests was observed when mutant (but not wild type) animals infected with different parasite strains were compared. CD4- mice produced high levels of IgG antibodies against peptide antigens or a whole homogenate from the parasite after infection with CA-I strain. A dramatic enhancement of IgG1- and IgG2a-specific antibodies was observed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622189     DOI: 10.1016/0165-2478(94)00221-c

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  24 in total

1.  Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection.

Authors:  M Saeftel; B Fleischer; A Hoerauf
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection.

Authors:  Andrea Henriques-Pons; Gabriel M Oliveira; Mauricio M Paiva; Alexandre F S Correa; Marcos M Batista; Rodrigo C Bisaggio; Chau-Ching Liu; Vinicius Cotta-De-Almeida; Claudia M L M Coutinho; Pedro M Persechini; Tania C Araujo-Jorge
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

3.  The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.

Authors:  Marcela L Ferraz; Ricardo T Gazzinelli; Rosana O Alves; Julio A Urbina; Alvaro J Romanha
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity.

Authors:  N M Quanquin; C Galaviz; D L Fouts; R A Wrightsman; J E Manning
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.

Authors:  C R Marinho; M R D'Império Lima; M G Grisotto; J M Alvarez
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue.

Authors:  R L Tarleton; L Zhang; M O Downs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen.

Authors:  Daniel F Hoft; Chris S Eickhoff
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice.

Authors:  T Sakai; H Hisaeda; Y Nakano; H Ishikawa; Y Maekawa; K Ishii; Y Nitta; J Miyazaki; K Himeno
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

9.  Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules.

Authors:  M G Grisotto; M R D'Império Lima; C R Marinho; C E Tadokoro; I A Abrahamsohn; J M Alvarez
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

10.  Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection.

Authors:  Yasushi Miyahira; Masaharu Katae; Seiki Kobayashi; Tsutomu Takeuchi; Yoshinosuke Fukuchi; Ryo Abe; Ko Okumura; Hideo Yagita; Takashi Aoki
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.